Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Rutkowski

Showing results (211-220 of 234) with videos related to

Pageof 24
Sort By:
Acta Neuropathologica|August 6, 2021
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Sophie C Henneken, Christina Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort StudyCraig Erker, Martin Mynarek, Simon Bailey, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Pediatric Blood & Cancer|March 17, 2026
The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and SwitzerlandStefan Rutkowski, Michael C Frühwald, Gudrun Fleischhack, et al.
Nature|April 17, 2020
Germline Elongator mutations in Sonic Hedgehog medulloblastomaSebastian M Waszak, Giles W Robinson, Brian L Gudenas, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed MedulloblastomaRahul Kumar, Kyle S Smith, Maximilian Deng, et al.
American Journal of Medical Genetics. Part A|February 8, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyTim Ripperger, Stefan S Bielack, Arndt Borkhardt, et al.
The Lancet. Oncology|April 18, 2015
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysisJonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, et al.
Pageof 24

Showing results (211-220 of 234) with videos related to

Sort By:
Pageof 24
Acta Neuropathologica|August 6, 2021
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Sophie C Henneken, Christina Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort StudyCraig Erker, Martin Mynarek, Simon Bailey, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Pediatric Blood & Cancer|March 17, 2026
The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and SwitzerlandStefan Rutkowski, Michael C Frühwald, Gudrun Fleischhack, et al.
Nature|April 17, 2020
Germline Elongator mutations in Sonic Hedgehog medulloblastomaSebastian M Waszak, Giles W Robinson, Brian L Gudenas, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed MedulloblastomaRahul Kumar, Kyle S Smith, Maximilian Deng, et al.
American Journal of Medical Genetics. Part A|February 8, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyTim Ripperger, Stefan S Bielack, Arndt Borkhardt, et al.
The Lancet. Oncology|April 18, 2015
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysisJonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, et al.
Pageof 24